Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada.
Nadine KronfliRoy NitulescuJoseph CoxErica Em MoodieAlexander WongCurtis CooperJohn GillSharon WalmsleyValérie Martel-LaferrièreMark W HullMarina B Kleinnull nullPublished in: Journal of the International AIDS Society (2019)
The majority of HIV-HCV co-infected persons had a history of incarceration. Those previously incarcerated were 30% less likely to access treatment in the DAA era even after accounting for several patient-level characteristics. With SVR rates above 90%, HCV elimination may be possible if treatment is expanded for this vulnerable and neglected group.